These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
249 related articles for article (PubMed ID: 33045064)
1. Transcription cofactor GRIP1 differentially affects myeloid cell-driven neuroinflammation and response to IFN-β therapy. Mimouna S; Rollins DA; Shibu G; Tharmalingam B; Deochand DK; Chen X; Oliver D; Chinenov Y; Rogatsky I J Exp Med; 2021 Jan; 218(1):. PubMed ID: 33045064 [TBL] [Abstract][Full Text] [Related]
2. The GRIP1:IRF3 interaction as a target for glucocorticoid receptor-mediated immunosuppression. Reily MM; Pantoja C; Hu X; Chinenov Y; Rogatsky I EMBO J; 2006 Jan; 25(1):108-17. PubMed ID: 16362036 [TBL] [Abstract][Full Text] [Related]
3. Smek1 deficiency exacerbates experimental autoimmune encephalomyelitis by activating proinflammatory microglia and suppressing the IDO1-AhR pathway. Duan RN; Yang CL; Du T; Liu A; Wang AR; Sun WJ; Li X; Li JX; Yan CZ; Liu QJ J Neuroinflammation; 2021 Jun; 18(1):145. PubMed ID: 34183017 [TBL] [Abstract][Full Text] [Related]
4. Angiopoietin-2 blockade ameliorates autoimmune neuroinflammation by inhibiting leukocyte recruitment into the CNS. Li Z; Korhonen EA; Merlini A; Strauss J; Wihuri E; Nurmi H; Antila S; Paech J; Deutsch U; Engelhardt B; Chintharlapalli S; Koh GY; Flügel A; Alitalo K J Clin Invest; 2020 Apr; 130(4):1977-1990. PubMed ID: 32149735 [TBL] [Abstract][Full Text] [Related]
6. A1 adenosine receptor upregulation and activation attenuates neuroinflammation and demyelination in a model of multiple sclerosis. Tsutsui S; Schnermann J; Noorbakhsh F; Henry S; Yong VW; Winston BW; Warren K; Power C J Neurosci; 2004 Feb; 24(6):1521-9. PubMed ID: 14960625 [TBL] [Abstract][Full Text] [Related]
8. LRP1 expression in microglia is protective during CNS autoimmunity. Chuang TY; Guo Y; Seki SM; Rosen AM; Johanson DM; Mandell JW; Lucchinetti CF; Gaultier A Acta Neuropathol Commun; 2016 Jul; 4(1):68. PubMed ID: 27400748 [TBL] [Abstract][Full Text] [Related]
9. Magnetic resonance imaging reveals therapeutic effects of interferon-beta on cytokine-induced reactivation of rat model of multiple sclerosis. Serres S; Bristow C; de Pablos RM; Merkler D; Soto MS; Sibson NR; Anthony DC J Cereb Blood Flow Metab; 2013 May; 33(5):744-53. PubMed ID: 23423190 [TBL] [Abstract][Full Text] [Related]
10. FGF/FGFR Pathways in Multiple Sclerosis and in Its Disease Models. Rajendran R; Böttiger G; Stadelmann C; Karnati S; Berghoff M Cells; 2021 Apr; 10(4):. PubMed ID: 33924474 [TBL] [Abstract][Full Text] [Related]
11. Lipocalin 2 is a novel immune mediator of experimental autoimmune encephalomyelitis pathogenesis and is modulated in multiple sclerosis. Berard JL; Zarruk JG; Arbour N; Prat A; Yong VW; Jacques FH; Akira S; David S Glia; 2012 Jul; 60(7):1145-59. PubMed ID: 22499213 [TBL] [Abstract][Full Text] [Related]
12. Myeloid cell transmigration across the CNS vasculature triggers IL-1β-driven neuroinflammation during autoimmune encephalomyelitis in mice. Lévesque SA; Paré A; Mailhot B; Bellver-Landete V; Kébir H; Lécuyer MA; Alvarez JI; Prat A; de Rivero Vaccari JP; Keane RW; Lacroix S J Exp Med; 2016 May; 213(6):929-49. PubMed ID: 27139491 [TBL] [Abstract][Full Text] [Related]
13. IFN-gamma shapes immune invasion of the central nervous system via regulation of chemokines. Tran EH; Prince EN; Owens T J Immunol; 2000 Mar; 164(5):2759-68. PubMed ID: 10679118 [TBL] [Abstract][Full Text] [Related]
14. Proteinase-activated receptor 2 modulates neuroinflammation in experimental autoimmune encephalomyelitis and multiple sclerosis. Noorbakhsh F; Tsutsui S; Vergnolle N; Boven LA; Shariat N; Vodjgani M; Warren KG; Andrade-Gordon P; Hollenberg MD; Power C J Exp Med; 2006 Feb; 203(2):425-35. PubMed ID: 16476770 [TBL] [Abstract][Full Text] [Related]
15. Induction of endogenous Type I interferon within the central nervous system plays a protective role in experimental autoimmune encephalomyelitis. Khorooshi R; Mørch MT; Holm TH; Berg CT; Dieu RT; Dræby D; Issazadeh-Navikas S; Weiss S; Lienenklaus S; Owens T Acta Neuropathol; 2015 Jul; 130(1):107-18. PubMed ID: 25869642 [TBL] [Abstract][Full Text] [Related]
16. The Role of Distinct Subsets of Macrophages in the Pathogenesis of MS and the Impact of Different Therapeutic Agents on These Populations. Radandish M; Khalilian P; Esmaeil N Front Immunol; 2021; 12():667705. PubMed ID: 34489926 [TBL] [Abstract][Full Text] [Related]
17. The benefits and detriments of macrophages/microglia in models of multiple sclerosis. Rawji KS; Yong VW Clin Dev Immunol; 2013; 2013():948976. PubMed ID: 23840244 [TBL] [Abstract][Full Text] [Related]
18. Myeloid Kruppel-like factor 2 deficiency exacerbates neurological dysfunction and neuroinflammation in a murine model of multiple sclerosis. Shi H; Sheng B; Zhang C; Nayak L; Lin Z; Jain MK; Atkins GB J Neuroimmunol; 2014 Sep; 274(1-2):234-9. PubMed ID: 25052583 [TBL] [Abstract][Full Text] [Related]
19. Absence of system x Merckx E; Albertini G; Paterka M; Jensen C; Albrecht P; Dietrich M; Van Liefferinge J; Bentea E; Verbruggen L; Demuyser T; Deneyer L; Lewerenz J; van Loo G; De Keyser J; Sato H; Maher P; Methner A; Massie A J Neuroinflammation; 2017 Jan; 14(1):9. PubMed ID: 28086920 [TBL] [Abstract][Full Text] [Related]